Teladoc Health, Inc. (4LL.F)
EUR 9.33
(-3.48%)
EUR 9.33
(-3.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 350.02 Million | 189.29 Million | 193.99 Million | -53.51 Million | 29.86 Million | -4.86 Million |
| Net Income | -220.36 Million | -13.65 Billion | -428.79 Million | -485.13 Million | -98.86 Million | -97.08 Million |
| Depreciation & Amortization | 351.32 Million | 270.64 Million | 219.62 Million | 78.08 Million | 44.95 Million | 35.6 Million |
| Deferred income taxes | -1.9 Million | -7.84 Million | 41.8 Million | -90.15 Million | -10.86 Million | -2.24 Million |
| Stock-based compensation | 201.55 Million | 217.85 Million | 302.58 Million | 475.53 Million | 66.7 Million | 43.76 Million |
| Change in working capital | 11.64 Million | -60.97 Million | -50.32 Million | -90.48 Million | -156 Thousand | -1.13 Million |
| Other non-cash items | 7.77 Million | 13.42 Billion | 109.1 Million | 58.64 Million | 28.1 Million | 16.23 Million |
| Investing Cash Flow | -156.34 Million | -167.74 Million | -72.98 Million | -590.97 Million | 25.01 Million | -257.49 Million |
| Investments in PPE | -156.34 Million | -172.76 Million | -63.93 Million | -26.04 Million | -10.9 Million | -8.4 Million |
| Acquisitions | - | - | -78.66 Million | -567.42 Million | -11.18 Million | -282.44 Million |
| Investment purchases | - | - | 63.93 Million | 26.04 Million | -5 Million | -56.34 Million |
| Sales/Maturities of investments | - | 2.5 Million | 60.9 Million | 2.49 Million | 52.1 Million | 84.17 Million |
| Other Investing Activities | 1000.00 | 2.51 Million | -55.21 Million | -26.04 Million | - | 5.53 Million |
| Financing Cash Flow | 10.85 Million | 6.49 Million | 40.94 Million | 859.13 Million | 35.09 Million | 645.61 Million |
| Debt repayment | - | - | -139 Thousand | -238.15 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 330.84 Million |
| Other Financing Activities | 10.85 Million | 6.49 Million | 41.08 Million | 1.09 Billion | 35.09 Million | 314.76 Million |
| Accounts receivables | -10.25 Million | -61.64 Million | -17.51 Million | -21.09 Million | -15.88 Million | -10.93 Million |
| Accounts payables | -4.18 Million | 1.87 Million | 1.18 Million | -87.99 Million | 905 Thousand | -391 Thousand |
| Inventory | 24.09 Million | 14.8 Million | -19.49 Million | -24.73 Million | 10.27 Million | 1.71 Million |
| Other working capital | 1.98 Million | -16 Million | -14.5 Million | 43.33 Million | 4.54 Million | 8.48 Million |
| Cash at beginning of period | 918.18 Million | 893.48 Million | 733.32 Million | 514.35 Million | 423.98 Million | 42.81 Million |
| Cash at end of period | 1.12 Billion | 918.18 Million | 893.48 Million | 733.32 Million | 514.35 Million | 423.98 Million |
| Capital Expenditure | -156.34 Million | -172.76 Million | -63.93 Million | -26.04 Million | -10.9 Million | -8.4 Million |
| Effect of forex changes on cash | 965 Thousand | -3.34 Million | -1.8 Million | 4.32 Million | 388 Thousand | -2.08 Million |
| Net cash flow / Change in cash | 205.49 Million | 24.7 Million | 160.15 Million | 218.97 Million | 90.36 Million | 381.17 Million |
| Free Cash Flow | 193.67 Million | 16.52 Million | 130.05 Million | -79.55 Million | 18.96 Million | -13.26 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -837.67 Million | -81.88 Million | -220.36 Million | -28.89 Million | -57.07 Million | -65.17 Million |
| Depreciation & Amortization | 98.85 Million | 100.5 Million | 351.32 Million | 101.48 Million | 97.49 Million | 78.83 Million |
| Deferred income taxes | 2.96 Million | -1.6 Million | -1.9 Million | 4.75 Million | -3.1 Million | -3.2 Million |
| Stock-based compensation | 42.1 Million | 42.32 Million | 201.55 Million | 46.82 Million | 52.96 Million | 55.72 Million |
| Change in working capital | -9.59 Million | -51.91 Million | 11.64 Million | 10.86 Million | 11.9 Million | 32.05 Million |
| Other non-cash items | 1.29 Million | 1.4 Million | 7.77 Million | -4.95 Million | 3.42 Million | 2.95 Million |
| Investing Cash Flow | -27.74 Million | -35.51 Million | -156.34 Million | -36.5 Million | -37.64 Million | -36.57 Million |
| Investments in PPE | -27.74 Million | -35.51 Million | -156.34 Million | -36.5 Million | -37.64 Million | -36.57 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -27.74 Million | - | 1000.00 | 1000.00 | - | - |
| Financing Cash Flow | 3.8 Million | 1.75 Million | 10.85 Million | -1.77 Million | 5.06 Million | 4.2 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -23 Thousand | 104 Thousand | 10.85 Million | -1.77 Million | 5.06 Million | 4.2 Million |
| Accounts receivables | -5.1 Million | 2.13 Million | -10.25 Million | -9.55 Million | 6.33 Million | 7.01 Million |
| Accounts payables | 18.48 Million | -5.87 Million | -4.18 Million | 17.48 Million | 10.11 Million | -22.65 Million |
| Inventory | -2.94 Million | -3.09 Million | 24.09 Million | 5.84 Million | -2.36 Million | 10.61 Million |
| Other working capital | -8.93 Million | 7.29 Million | 1.98 Million | -2.91 Million | -2.18 Million | 37.08 Million |
| Cash at beginning of period | 1.09 Billion | 1.12 Billion | 918.18 Million | 1.03 Billion | 958.69 Million | 888.57 Million |
| Cash at end of period | 1.16 Billion | 1.09 Billion | 1.12 Billion | 1.12 Billion | 1.03 Billion | 958.69 Million |
| Capital Expenditure | -27.74 Million | -35.51 Million | -156.34 Million | -36.5 Million | -37.64 Million | -36.57 Million |
| Effect of forex changes on cash | -292 Thousand | -899 Thousand | 965 Thousand | 1.34 Million | -1.19 Million | 1.29 Million |
| Net cash flow / Change in cash | 64.44 Million | -25.74 Million | 205.49 Million | 93.14 Million | 71.83 Million | 70.11 Million |
| Free Cash Flow | 60.93 Million | -26.59 Million | 193.67 Million | 93.57 Million | 67.95 Million | 64.61 Million |
600979
PMEDF
4348
GFIN
9136
NAGTECH